论文部分内容阅读
目的:观察用黄芪注射液辅助西药治疗急性病毒性心肌炎的临床疗效。方法:对2008年6月～2011年6月期间在我科住院治疗的80例急性病毒性心肌炎患者的临床资料进行回顾性研究。我们将这80例患者随机分为对照组和治疗组,每组各有40例患者。对照组患者进行常规西药治疗,治疗组患者在进行常规西药治疗的基础上,加用黄芪注射液进行治疗。治疗14天后,比较两组患者治疗的效果和发生不良反应的情况。结果:经过14天的治疗,治疗组患者治疗的总有效率为97.5%,对照组患者治疗的总有效率为85.0%,治疗组患者治疗的总有效率明显高于对照组患者,二者相比差异具有显著性(P<0.05)。在治疗期间,两组患者的血常规、尿常规、血糖、肝肾功能等指标均未发生明显变化,二者相比差异无显著性。结论:用黄芪注射液辅助西药治疗急性病毒性心肌炎效果显著,不良反应少,值得在临床上推广使用。
Objective: To observe the clinical efficacy of Astragalus injection in the treatment of acute viral myocarditis. Methods: The clinical data of 80 patients with acute viral myocarditis hospitalized in our department from June 2008 to June 2011 were retrospectively studied. We randomly divided these 80 patients into control and treatment groups, each with 40 patients in each group. Patients in the control group were treated with conventional western medicine. Patients in the treatment group were treated with Astragalus injection on the basis of conventional western medicine treatment. After 14 days of treatment, the effects of treatment and adverse reactions in both groups were compared. Results: After 14 days of treatment, the total effective rate of the treatment group was 97.5%, while the total effective rate of the control group was 85.0%. The total effective rate of the treatment group was significantly higher than that of the control group The difference was significant (P <0.05). During the treatment period, no significant changes were observed in blood routine, urine routine, blood glucose, liver and kidney function, and the two groups showed no significant difference. Conclusion: Astragalus injection Western medicine treatment of acute viral myocarditis significant effect, fewer adverse reactions, it is worth promoting in clinical use.